PL1977252T3 - Ulepszony test aktywacji monocytów o lepszej zdolności do wykrywania nieendotoksynowego skażenia pirogennego w produktach medycznych - Google Patents

Ulepszony test aktywacji monocytów o lepszej zdolności do wykrywania nieendotoksynowego skażenia pirogennego w produktach medycznych

Info

Publication number
PL1977252T3
PL1977252T3 PL06846727T PL06846727T PL1977252T3 PL 1977252 T3 PL1977252 T3 PL 1977252T3 PL 06846727 T PL06846727 T PL 06846727T PL 06846727 T PL06846727 T PL 06846727T PL 1977252 T3 PL1977252 T3 PL 1977252T3
Authority
PL
Poland
Prior art keywords
medical products
detect non
monocyte activation
activation test
improved monocyte
Prior art date
Application number
PL06846727T
Other languages
English (en)
Inventor
Stephen Poole
Mehul Patel
Original Assignee
Baxter Int
Baxter Healthcare Sa
The Sec Dep For Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int, Baxter Healthcare Sa, The Sec Dep For Health filed Critical Baxter Int
Publication of PL1977252T3 publication Critical patent/PL1977252T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869Interleukin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • G01N33/5055Cells of the immune system involving macrophages
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/54Interleukins [IL]
    • G01N2333/5412IL-6
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/70Mechanisms involved in disease identification
    • G01N2800/7095Inflammation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL06846727T 2005-12-22 2006-12-20 Ulepszony test aktywacji monocytów o lepszej zdolności do wykrywania nieendotoksynowego skażenia pirogennego w produktach medycznych PL1977252T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75297005P 2005-12-22 2005-12-22
EP06846727A EP1977252B1 (en) 2005-12-22 2006-12-20 Improved monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
PCT/US2006/062424 WO2007076411A1 (en) 2005-12-22 2006-12-20 Improved monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products

Publications (1)

Publication Number Publication Date
PL1977252T3 true PL1977252T3 (pl) 2013-07-31

Family

ID=37913652

Family Applications (2)

Application Number Title Priority Date Filing Date
PL06846727T PL1977252T3 (pl) 2005-12-22 2006-12-20 Ulepszony test aktywacji monocytów o lepszej zdolności do wykrywania nieendotoksynowego skażenia pirogennego w produktach medycznych
PL11003878T PL2360479T3 (pl) 2005-12-22 2006-12-20 Ulepszony test aktywacji monocytów o lepszej zdolności do wykrywania nieendotoksynowego skażenia pirogennego w produktach medycznych

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL11003878T PL2360479T3 (pl) 2005-12-22 2006-12-20 Ulepszony test aktywacji monocytów o lepszej zdolności do wykrywania nieendotoksynowego skażenia pirogennego w produktach medycznych

Country Status (16)

Country Link
US (5) US7736863B2 (pl)
EP (2) EP1977252B1 (pl)
JP (1) JP4686611B2 (pl)
KR (1) KR101352222B1 (pl)
CN (2) CN103901208B (pl)
AU (1) AU2006330562B2 (pl)
BR (1) BRPI0620434A2 (pl)
CA (1) CA2633523A1 (pl)
DK (2) DK1977252T3 (pl)
ES (2) ES2477588T3 (pl)
HK (3) HK1161638A1 (pl)
MX (1) MX2008008138A (pl)
PL (2) PL1977252T3 (pl)
PT (2) PT2360479E (pl)
SG (1) SG179468A1 (pl)
WO (1) WO2007076411A1 (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101352222B1 (ko) * 2005-12-22 2014-02-04 백스터 인터내셔널 인코포레이티드 의료용 제품에서 비-내독소 발열성 오염물을 보다 잘검출할 수 있는 개선된 단핵구 활성화 시험
DE102006031483B4 (de) * 2006-07-07 2009-12-24 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Zellulärer Pyrogentest
JP4148367B1 (ja) 2007-08-02 2008-09-10 富山県 細胞のスクリーニング方法
WO2009063307A2 (en) * 2007-11-14 2009-05-22 Bio-Technology General (Israel) Ltd. Inflammatory activity detection method using il-6
KR20180001596A (ko) * 2008-01-18 2018-01-04 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 체액 내에서 질병 또는 병태의 시그너쳐의 검출 방법
EP2273995B2 (en) 2008-03-20 2023-11-15 Baxter International Inc. Destruction of microbial products by enzymatic digestion
US20090239819A1 (en) * 2008-03-20 2009-09-24 Run Wang Peritoneal dialysis solution test method
US20090239238A1 (en) * 2008-03-20 2009-09-24 Baxter International Inc. Methods for measuring pro-inflammatory substance levels in dialysis solutions and dialysis components
ES2509616T3 (es) 2009-06-25 2014-10-17 Nestec S.A. Procedimientos de diagnóstico del síndrome del intestino irritable
WO2012012694A2 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
AU2011280936A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
FR2978774B1 (fr) * 2011-08-02 2015-02-20 Roquette Freres Methodes de detection des contaminants des circuits de production de polymeres de glucose
SG10201602761TA (en) 2011-04-08 2016-05-30 Roquette Freres Methods For Detecting Contaminants Of Glucose Polymers
MX356623B (es) * 2011-09-01 2018-06-06 Fresenius Medical Care Holdings Inc Equipo para muestreo y deteccion de endotoxina en solucion acuosa.
HUE029269T2 (en) 2011-12-21 2017-02-28 Grifols Sa Identification of atypical antibodies in human blood and blood products
ES2672980T3 (es) * 2012-05-29 2018-06-19 Roquette Frères Métodos para descontaminar circuitos de producción de polímeros de glucosa e hidrolizados de polímeros de glucosa
EP2901156B1 (en) * 2012-09-26 2018-06-20 Cook Biotech Incorporated Medical device design, manufacture and testing systems
WO2015140477A1 (fr) 2014-03-21 2015-09-24 Roquette Freres Procede optimise de decontamination de production de polymeres de glucose et d'hydrolysats de polymeres de glucose
JP6948950B2 (ja) 2015-03-27 2021-10-13 レゲネロン ファーマシューティカルス,インコーポレーテッド メイタンシノイド誘導体、そのコンジュゲート、及び使用方法
FR3037063B1 (fr) 2015-06-04 2017-05-19 Roquette Freres Procede optimise de decontamination de l'amidon utilise comme matiere premiere pour l'obtention de polymeres de glucose destines a la dialyse peritoneale
EP3171170A1 (en) * 2015-11-17 2017-05-24 Lionex GmbH Device for use in elispot
KR20190074310A (ko) 2016-11-08 2019-06-27 리제너론 파마슈티칼스 인코포레이티드 스테로이드 및 이의 단백질-접합체
US20220412958A1 (en) * 2019-11-19 2022-12-29 Mican Technologies Inc. Method for evaluating safety of substance in vitro using human immortalized myeloid cells
EP4006546A1 (en) * 2020-11-30 2022-06-01 Medizinische Hochschule Hannover Application of stem-cell derived monocytes in a monocyte activation test (mat) for the assessment of pyrogenicity and inflammatory potential
WO2024052376A1 (en) * 2022-09-06 2024-03-14 Mat Research B.V. Improved monocyte activation test

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4434237A (en) 1982-03-31 1984-02-28 Dinarello Charles A Human leukocytic pyrogen test for the detection of exogenous fever-producing substances
FR2615622B1 (fr) 1987-05-19 1994-05-06 Ire Medgenix Sa Dosage plasmatique de monokines
US5281540A (en) 1988-08-02 1994-01-25 Abbott Laboratories Test array for performing assays
FR2679659B1 (fr) 1991-07-23 1993-11-19 Medgenix Diagnostic Sa Procede de dosage in vitro de molecules au niveau de leur site de production par des cellules en culture et format technologique adapte.
JPH07509783A (ja) 1992-10-30 1995-10-26 ティー セル ダイアグノスティックス,インコーポレーテッド 試料中の全分子の測定及びそれに基づく方法
FR2699283B1 (fr) 1992-12-15 1995-03-03 Medgenix Diagnostic Test de pyrogénicite et kit de mise en Óoeuvre.
AU693437B2 (en) 1993-12-28 1998-07-02 Chiron Mimotopes Pty Ltd T-cell epitopes
DE19516247A1 (de) 1995-05-03 1996-11-07 Albrecht Prof Dr Wendel Pyrogen-Untersuchungsverfahren
US5910287A (en) * 1997-06-03 1999-06-08 Aurora Biosciences Corporation Low background multi-well plates with greater than 864 wells for fluorescence measurements of biological and biochemical samples
EP1234181A4 (en) * 1999-12-03 2005-01-26 Baxter Int PYROGENICITY TEST FOR USE WITH AUTOMATED IMMUNOLOGICAL ASSAY SYSTEMS
US20040029210A1 (en) * 2000-12-12 2004-02-12 Robillot Cedric Emile Francois Assay for paralytic shellfish toxin
EP1474511B1 (en) * 2002-02-12 2005-04-27 Biotage AB Separating method and an apparatus performing such a method
GB0207350D0 (en) * 2002-03-28 2002-05-08 Univ Sheffield Surface
KR101352222B1 (ko) * 2005-12-22 2014-02-04 백스터 인터내셔널 인코포레이티드 의료용 제품에서 비-내독소 발열성 오염물을 보다 잘검출할 수 있는 개선된 단핵구 활성화 시험

Also Published As

Publication number Publication date
PT1977252E (pt) 2013-01-28
HK1199753A1 (en) 2015-07-17
ES2400965T8 (es) 2013-06-04
ES2477588T3 (es) 2014-07-17
CN103901208B (zh) 2016-08-24
CN101346630A (zh) 2009-01-14
US8058021B2 (en) 2011-11-15
US9671411B2 (en) 2017-06-06
EP2360479A3 (en) 2011-08-31
DK2360479T3 (da) 2014-04-07
PL2360479T3 (pl) 2014-09-30
EP2360479B1 (en) 2014-04-02
JP2009521690A (ja) 2009-06-04
CN101346630B (zh) 2013-07-17
DK1977252T3 (da) 2013-03-04
EP1977252A1 (en) 2008-10-08
US20120058559A1 (en) 2012-03-08
MX2008008138A (es) 2008-11-28
JP4686611B2 (ja) 2011-05-25
EP1977252B1 (en) 2012-12-05
AU2006330562A1 (en) 2007-07-05
HK1119243A1 (en) 2009-02-27
HK1161638A1 (en) 2012-07-27
US9023647B2 (en) 2015-05-05
US20100203551A1 (en) 2010-08-12
EP2360479A2 (en) 2011-08-24
KR20080080400A (ko) 2008-09-03
PT2360479E (pt) 2014-07-10
US20070184496A1 (en) 2007-08-09
SG179468A1 (en) 2012-04-27
US20150285819A1 (en) 2015-10-08
KR101352222B1 (ko) 2014-02-04
US20100203557A1 (en) 2010-08-12
WO2007076411A1 (en) 2007-07-05
US8053200B2 (en) 2011-11-08
CA2633523A1 (en) 2007-07-05
AU2006330562B2 (en) 2013-05-02
ES2400965T3 (es) 2013-04-15
CN103901208A (zh) 2014-07-02
US7736863B2 (en) 2010-06-15
BRPI0620434A2 (pt) 2011-11-16

Similar Documents

Publication Publication Date Title
HK1199753A1 (en) Improved monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
PL2043786T3 (pl) Zestaw do analizy przeznaczony do użytku w urządzeniach do analizy
EP2004302A4 (en) ELECTRETS AND COMPOUNDS USEFUL IN ELECTRETS
GB0522015D0 (en) Improvements in or relating to sensing apparatus
EP1857036A4 (en) DEVICE AND SYSTEM TO BE INTRODUCED IN A SUBJECT
GB0723179D0 (en) Diagnostic methods and arrays for use in the same
GB2432772B (en) Improvements in and relating to nutritional products
GB2463980B (en) Ruthenium complex and photoelectric component using the same
EP2321320A4 (en) NEW COMPOUNDS AND THEIR USES IN DIAGNOSIS
GB2464595B (en) Ruthenium complex and photoelectric component using the same
GB0523166D0 (en) Improvements in and relating to medical products
GB0818946D0 (en) Improvements in physiological movement monitoring
GB2432668B (en) Improvements in and relating to monitoring
GB2430345B (en) Improvements in or relating to snack products
GB2463096B (en) Improvements in or relating to health and saftey
GB0702532D0 (en) Improvements in or relating to rubber products
GB0513717D0 (en) Improvements in and relating to monitoring
GB0513750D0 (en) Improvements in and relating to monitoring
GB0512329D0 (en) Improvements in or relating to electrical apparatus
ITBA20050020A1 (it) Pouf e sistema per trasformarlo in letto
GB0511315D0 (en) Improvements in or relating to tourniquet
GB0523620D0 (en) Improvements in or relating to tourniquet
GB0505982D0 (en) Improvements in or relating to furniture
GB0613346D0 (en) Improvents in and relating to monitoring
GB0820464D0 (en) Mattresses and upholstered units